Brind.

Amie Phinney was hired as Strategy & Business Advisor by Defence Therapeutics.

2 reports, 2 independent Updated Aug 4

Gone quiet

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Amie Phinney was hired as Strategy & Business Advisor by Defence Therapeutics.

Who's involved

What this event is mainly about

Defence Therapeutics AbbVie

How it developed

Newest first. Tap a step to see who reported it.

Aug 4Dr. Amie Phinney is promoted to President and CEO of Defence Therapeutics.1 source
- finanznachrichten.de
Sep 2Amie Phinney joins Defence Therapeutics after previous roles at AbbVie and Abbott.1 source
- Newsfile

Keep exploring

The entities involved

Defence Therapeutics
Nothing else this week.
AbbVie
pharmaceutical company
- MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
- AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48

Coverage

Newest first; wire copies grouped

Aug 4finanznachrichten.de
Sep 2NewsfileDefence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC